These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6103632)

  • 41. A comparison between some biochemical and behavioural effects produced by neuroleptics.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stress effect on haloperidol-induced catalepsy and its circadian rhythm in intact and ovariectomized female rats].
    Baturin VA; Manvelian ÉA; Bulgakova MD
    Eksp Klin Farmakol; 2012; 75(5):3-6. PubMed ID: 22834120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacological investigations of the central action of benzydamine.
    Kocur J; Czarnecka E; Kaminska A; Wejman I
    Agressologie; 1978; 19(1):29-33. PubMed ID: 569446
    [No Abstract]   [Full Text] [Related]  

  • 44. Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat.
    Ionov ID; Severtsev NN
    Pharmacol Biochem Behav; 2012 Dec; 103(2):295-8. PubMed ID: 23036801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neurochemical aspects of corrective effect of fluoracizine in triphthazine-induced catalepsy in rats].
    Vikhliaev IuI; Lando LI; Artemenko GN; Krupenina LB; Ul'ianova OV
    Farmakol Toksikol; 1976; 39(4):407-11. PubMed ID: 1036166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haloperidol in large doses reduces the cataleptic response and increases noradrenaline metabolism in the brain of the rat.
    Toru M; Takashima M
    Neuropharmacology; 1985 Mar; 24(3):231-6. PubMed ID: 4039420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lithium modifications of the cataleptogenic properties of various neuroleptic drugs in the rat].
    Dessaigne S; Scotto AM; Guigues M
    C R Seances Soc Biol Fil; 1978; 172(6):1173-80. PubMed ID: 40676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4.
    Asin KE; Wirtshafter D; Fibiger HC
    Life Sci; 1982 May; 30(18):1531-6. PubMed ID: 7200562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of albumin degradation products (ADP) on the central action of catecholamines.
    Tarasiewicz S; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticataleptic action of psychostimulating drugs and serotonin in brain.
    Malec D; Langwiński R
    Acta Physiol Pol; 1979; 30(5-6):589-95. PubMed ID: 161138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
    Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
    Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat.
    György L; Pfeifer KA; Hajtman B
    Psychopharmacologia; 1969; 16(3):223-33. PubMed ID: 5391697
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropharmacology; 1985 Jun; 24(6):577-80. PubMed ID: 2862602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
    Kasture S; Barhate S; Mohan M; Ballero M; Sanna C; Maxia A
    Nat Prod Res; 2009; 23(8):724-8. PubMed ID: 19418355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in apomorphine concentration in spinal cord and brain follow the time course of catalepsies induced by different treatments.
    Kolasiewicz W; Harasiewicz A; Melzacka M; Wolfarth S
    Exp Neurol; 1983 Jul; 81(1):195-209. PubMed ID: 6861947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice.
    Fujiwara H
    Pharmacol Biochem Behav; 1992 Feb; 41(2):301-8. PubMed ID: 1349435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
    Zebrowska-Lupina I; Porowska A
    Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catecholamines in the rat brain during hypoglycemic convulsions and coma.
    Losy J; Bernat R
    Acta Physiol Pol; 1989; 40(5-6):479-85. PubMed ID: 2488745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.